Featured Posts
News Release
FDA deserves credit for approval pancreatic cancer drug
The FDA on August 26 approved a new breakthrough drug to treat pancreatic cancer. CEI Senior Fellow and Economist Jeremy Nighohossian praised…
Blog
Fauci’s lasting legacy will be the damage he did to science and government
Anthony Fauci isn’t faring well in the court of public opinion. His recently divulged “diary” and subsequent July 29 appearance before the Senate Homeland…
News Release
FDA commissioner resignation opens opportunity for refocus on science over politics
After a somewhat tumultuous tenure, FDA commissioner Marty Makary is stepping down. While Dr. Makary made his mission to accelerate drug approval and bring…
Search Posts
Study
Public Stem Cell Research Funding
The best way to make progress in stem cell research is to allow the private sector to grow, unimpeded by regulation and controversy.
Newsletter
Fannie Mae, HIV Rates and Greenhouse Gases
Mortgage giant Fannie Mae announces a shakeup of its senior management. A new study finds New York City’s HIV infection rate to be three times…
Newsletter
West Nile, Union Corruption and Federal Courts
The West Nile Virus has infected individuals in 28 states so far this year. The Los Angeles Times publishes a 3-part series on corruption allegations…
Op-Eds
Sick Patients Need Cutting-Edge Drugs
The story of Anna Tomalis trying to recieve a compassionate usage exemption from the FDA to treat her cancer.
Newsletter
Drug Approval at the FDA, Childhood Obesity and the War on Bottled Water
Industry analysts characterize the Food and Drug Administration’s drug approval process as especially “conservative.” An anti-obesity advertising campaign targeted at children generates controversy. Local government…
News Release
Reform Needed at the Food and Drug Administration
Washington, D.C., August 14, 2008—In order to best serve the interests of the nation’s patients and doctors, the structure of the…